Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines
- PMID: 25874340
- DOI: 10.1016/j.ejmech.2015.04.003
Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines
Abstract
Heme oxygenase (HO) is a cytoprotective enzyme that can be overexpressed in some pathological conditions, including certain cancers. In this work, novel imidazole derivatives were designed and synthesized as inhibitors of heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2). In these compounds the imidazole ring, crucial for the activity, is connected to a hydrophobic group, represented by aryloxy, benzothiazole, or benzoxazole moieties, by means of alkyl or thioalkyl chains of different length. Many of the tested compounds were potent and/or selective against one of the two isoforms of HO. Furthermore, most of the pentyl derivatives showed to be better inhibitors of HO-2 with respect to HO-1, revealing a critical role of the alkyl chain in discriminating between the two isoenzymes. Compounds which showed the better profile of HO inhibition were selected and tested to evaluate their cytotoxic properties in prostate and breast cancer cell lines (DU-145, PC3, LnCap, MDA-MB-231, and MCF-7). In these assays, aryloxyalkyl derivatives resulted more cytotoxic than benzothiazolethioalkyl ones; in particular compound 31 was active against all the cell lines tested, confirming the anti-proliferative properties of HO inhibitors and their potential use in the treatment of specific cancers.
Keywords: Anti-cancer; Anti-proliferative properties; HO-1; HO-2; Heme oxygenase; Inhibitors.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Immune Modulation by Inhibitors of the HO System.Int J Mol Sci. 2020 Dec 30;22(1):294. doi: 10.3390/ijms22010294. Int J Mol Sci. 2020. PMID: 33396647 Free PMC article. Review.
-
New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells.Int J Mol Sci. 2020 Mar 11;21(6):1923. doi: 10.3390/ijms21061923. Int J Mol Sci. 2020. PMID: 32168943 Free PMC article.
-
Development and characterization of a new inhibitor of heme oxygenase activity for cancer treatment.Arch Biochem Biophys. 2019 Aug 15;671:130-142. doi: 10.1016/j.abb.2019.07.002. Epub 2019 Jul 2. Arch Biochem Biophys. 2019. PMID: 31276659
-
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.Eur J Med Chem. 2019 Apr 1;167:439-453. doi: 10.1016/j.ejmech.2019.02.027. Epub 2019 Feb 12. Eur J Med Chem. 2019. PMID: 30784878 Review.
-
Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.Bioorg Med Chem. 2013 Sep 1;21(17):5145-53. doi: 10.1016/j.bmc.2013.06.040. Epub 2013 Jun 26. Bioorg Med Chem. 2013. PMID: 23867390
Cited by
-
Synthesis and in Vitro Evaluation of CAPE Derivatives as Ferroptosis Inducers in Triple Negative Breast Cancer.ACS Med Chem Lett. 2024 Apr 30;15(5):706-713. doi: 10.1021/acsmedchemlett.4c00099. eCollection 2024 May 9. ACS Med Chem Lett. 2024. PMID: 38746881
-
Pharmacological Significance of Heme Oxygenase 1 in Prostate Cancer.Curr Issues Mol Biol. 2023 May 15;45(5):4301-4316. doi: 10.3390/cimb45050273. Curr Issues Mol Biol. 2023. PMID: 37232742 Free PMC article. Review.
-
The impact of heme oxygenase-2 on pharmacological research: A bibliometric analysis and beyond.Front Pharmacol. 2023 Apr 19;14:1156333. doi: 10.3389/fphar.2023.1156333. eCollection 2023. Front Pharmacol. 2023. PMID: 37153762 Free PMC article.
-
Heme Oxygenase Modulation Drives Ferroptosis in TNBC Cells.Int J Mol Sci. 2022 May 20;23(10):5709. doi: 10.3390/ijms23105709. Int J Mol Sci. 2022. PMID: 35628518 Free PMC article.
-
From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes.Pharmaceuticals (Basel). 2021 Dec 10;14(12):1289. doi: 10.3390/ph14121289. Pharmaceuticals (Basel). 2021. PMID: 34959690 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
Miscellaneous